<DOC>
	<DOC>NCT02953366</DOC>
	<brief_summary>The purpose of this study is to evaluate the non-inferiority of the clinical efficacy of the mometasone nasal gel in the treatment of allergic rhinitis.</brief_summary>
	<brief_title>Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Signed Consent of the patient; Clinical diagnosis of moderate severe persistent allergic rhinitis according to ARIA classification(Allergic Rhinitis and Its Impact on Asthma); Patients with any clinically significant disease that in the investigator is opinion can´t participate in the study; Patients with any laboratory finding or image finding that in the investigator is opinion can´t participate in the clinical trial; Patients with history of hypersensitivity to any of the formula compounds; Participation in clinical trial in the year prior to this study; Pregnancy or risk of pregnancy and lactating patients; Patients who were in use of drugs that can interfere with evaluation; Decongestants dependent patients or patients receiving allergen specific immunotherapy; Patients on treatment with monoamine oxidase inhibitors (MAOIs).</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>